vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $196.0M, roughly 1.4× Axsome Therapeutics, Inc.). Axsome Therapeutics, Inc. runs the higher net margin — -14.6% vs -32.2%, a 17.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 14.1%). Getty Images Holdings, Inc. produced more free cash flow last quarter ($7.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 12.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
AXSM vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $282.3M |
| Net Profit | $-28.6M | $-90.9M |
| Gross Margin | — | 74.8% |
| Operating Margin | -13.8% | -8.5% |
| Net Margin | -14.6% | -32.2% |
| Revenue YoY | 65.0% | 14.1% |
| Net Profit YoY | 61.9% | -467.6% |
| EPS (diluted) | $-0.55 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $282.3M | ||
| Q3 25 | $171.0M | $240.0M | ||
| Q2 25 | $150.0M | $234.9M | ||
| Q1 25 | $121.5M | $224.1M | ||
| Q4 24 | $118.8M | $247.3M | ||
| Q3 24 | $104.8M | $240.5M | ||
| Q2 24 | $87.2M | $229.1M | ||
| Q1 24 | $75.0M | $222.3M |
| Q4 25 | $-28.6M | $-90.9M | ||
| Q3 25 | $-47.2M | $21.6M | ||
| Q2 25 | $-48.0M | $-34.4M | ||
| Q1 25 | $-59.4M | $-102.6M | ||
| Q4 24 | $-74.9M | $24.7M | ||
| Q3 24 | $-64.6M | $-2.5M | ||
| Q2 24 | $-79.3M | $3.7M | ||
| Q1 24 | $-68.4M | $13.6M |
| Q4 25 | — | 74.8% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.1% | ||
| Q4 24 | — | 73.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 72.5% | ||
| Q1 24 | — | 72.9% |
| Q4 25 | -13.8% | -8.5% | ||
| Q3 25 | -27.0% | 18.8% | ||
| Q2 25 | -24.5% | 15.1% | ||
| Q1 25 | -46.9% | 12.2% | ||
| Q4 24 | -61.1% | 14.5% | ||
| Q3 24 | -59.8% | 23.9% | ||
| Q2 24 | -89.5% | 20.3% | ||
| Q1 24 | -89.7% | 18.5% |
| Q4 25 | -14.6% | -32.2% | ||
| Q3 25 | -27.6% | 9.0% | ||
| Q2 25 | -32.0% | -14.6% | ||
| Q1 25 | -48.9% | -45.8% | ||
| Q4 24 | -63.1% | 10.0% | ||
| Q3 24 | -61.7% | -1.1% | ||
| Q2 24 | -91.0% | 1.6% | ||
| Q1 24 | -91.1% | 6.1% |
| Q4 25 | $-0.55 | $-0.22 | ||
| Q3 25 | $-0.94 | $0.05 | ||
| Q2 25 | $-0.97 | $-0.08 | ||
| Q1 25 | $-1.22 | $-0.25 | ||
| Q4 24 | $-1.54 | $0.07 | ||
| Q3 24 | $-1.34 | $-0.01 | ||
| Q2 24 | $-1.67 | $0.01 | ||
| Q1 24 | $-1.44 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $90.2M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $88.3M | $552.5M |
| Total Assets | $689.8M | $3.2B |
| Debt / EquityLower = less leverage | — | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $90.2M | ||
| Q3 25 | $325.3M | $109.5M | ||
| Q2 25 | $303.0M | $110.3M | ||
| Q1 25 | $300.9M | $114.6M | ||
| Q4 24 | $315.4M | $121.2M | ||
| Q3 24 | $327.3M | $109.9M | ||
| Q2 24 | $315.7M | $121.7M | ||
| Q1 24 | $331.4M | $134.2M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $88.3M | $552.5M | ||
| Q3 25 | $73.7M | $634.6M | ||
| Q2 25 | $73.1M | $611.2M | ||
| Q1 25 | $53.2M | $593.0M | ||
| Q4 24 | $57.0M | $670.2M | ||
| Q3 24 | $92.9M | $683.4M | ||
| Q2 24 | $102.9M | $654.0M | ||
| Q1 24 | $144.0M | $640.8M |
| Q4 25 | $689.8M | $3.2B | ||
| Q3 25 | $669.3M | $2.6B | ||
| Q2 25 | $639.8M | $2.6B | ||
| Q1 25 | $596.7M | $2.6B | ||
| Q4 24 | $568.5M | $2.6B | ||
| Q3 24 | $561.5M | $2.6B | ||
| Q2 24 | $548.2M | $2.6B | ||
| Q1 24 | $545.7M | $2.6B |
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.21× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $20.6M |
| Free Cash FlowOCF − Capex | $-18.7M | $7.7M |
| FCF MarginFCF / Revenue | -9.6% | 2.7% |
| Capex IntensityCapex / Revenue | 0.0% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $20.6M | ||
| Q3 25 | $1.0M | $22.6M | ||
| Q2 25 | $-32.4M | $6.5M | ||
| Q1 25 | $-43.4M | $15.4M | ||
| Q4 24 | $-26.2M | $39.7M | ||
| Q3 24 | $-18.6M | $10.7M | ||
| Q2 24 | $-30.1M | $46.4M | ||
| Q1 24 | $-53.5M | $21.5M |
| Q4 25 | $-18.7M | $7.7M | ||
| Q3 25 | $988.0K | $7.9M | ||
| Q2 25 | $-32.4M | $-9.6M | ||
| Q1 25 | $-43.7M | $-322.0K | ||
| Q4 24 | $-26.2M | $24.6M | ||
| Q3 24 | $-18.7M | $-1.8M | ||
| Q2 24 | $-30.2M | $31.1M | ||
| Q1 24 | $-53.6M | $7.1M |
| Q4 25 | -9.6% | 2.7% | ||
| Q3 25 | 0.6% | 3.3% | ||
| Q2 25 | -21.6% | -4.1% | ||
| Q1 25 | -36.0% | -0.1% | ||
| Q4 24 | -22.1% | 9.9% | ||
| Q3 24 | -17.9% | -0.8% | ||
| Q2 24 | -34.6% | 13.6% | ||
| Q1 24 | -71.4% | 3.2% |
| Q4 25 | 0.0% | 4.6% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | 0.0% | 6.9% | ||
| Q1 25 | 0.3% | 7.0% | ||
| Q4 24 | 0.0% | 6.1% | ||
| Q3 24 | 0.1% | 5.2% | ||
| Q2 24 | 0.1% | 6.7% | ||
| Q1 24 | 0.1% | 6.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.59× | ||
| Q1 24 | — | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
